MedTrace Logo

Exercise Approaches and Physical Activity Level in Inactive Adults

NCT07411248 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-02-13

No results posted yet for this study

Summary

This randomized, controlled, single-blind study aims to compare the effects of different exercise approaches on physical activity level and health-related outcomes in inactive adults. Thirty inactive individuals aged 18-35 years will be randomly assigned to supervised face-to-face group exercise, mobile application-based exercise, or video-based home exercise. Exercise programs will be performed three days per week for eight weeks and will include aerobic, strengthening, and flexibility exercises.

Conditions

  • Healthy Participants
  • Inactivity
  • Exercise Training

Interventions

OTHER

Face-to-Face Supervised Exercise

Participants will perform supervised face-to-face group exercise sessions three days per week for eight weeks under the guidance of a physiotherapist. Each session will include aerobic, strengthening, and flexibility exercises.

DEVICE

Mobile App-Based Exercise

Participants will perform exercise sessions using the Nike+ Training Club mobile application three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises delivered through asynchronous video content.

OTHER

Home-Based Video Exercise

Participants will perform video-based home exercise sessions using the "Walk at Home: Leslie" program three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-06
Primary Completion
2026-03-02
Completion
2026-03-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07411248 on ClinicalTrials.gov